文献速递肝胆胰外科

102例实性假乳头状肿瘤中腹腔镜与开腹胰腺切除术的结局和生存相似

Outcome and survival were similar with laparoscopic and open pancreatectomy in 102 solid pseudopapillary neoplasms.
PubMed 文献 · Surg Endosc · 2024-03-06

该单中心回顾性队列研究纳入2001至2021年102例实性假乳头状肿瘤(SPNP)胰腺切除患者,比较腹腔镜(LA,40例)与开腹(OA,62例)的围术期及长期结局。结果显示两组人群特征无显著差异,LA组胰十二指肠切除术比例较低、远端胰腺切除术比例较高;按术式分层后LA在部分术式中有失血量少、手术时间短等优势,中位随访60个月复发2例且与手术入路无关。作者结论认为LA治疗SPNP似乎是安全的,但大病灶行胰十二指肠切除术时应谨慎应用,且与复发无关。

要点

  • LA组胰十二指肠切除术比例低于OA组(25% vs 53%,p=0.004),远端胰腺切除术比例高于OA组(40% vs 16%,p=0.003)。
  • LA-DP组中位手术时间135 vs 190分钟(p=0.028),中位综合并发症指数评分0 vs 8.7(p=0.048)。
  • 中位随访60个月,复发2例(2%),与手术入路无关。

核心结论

  • 作者认为腹腔镜入路治疗SPNP似乎是安全的,在大病灶行胰十二指肠切除术时应谨慎应用,且与复发无关。

研究设计与样本

  • 单中心回顾性队列研究,纳入2001至2021年因SPNP行胰腺切除术的102例患者(84%为女性,中位年龄30岁),比较腹腔镜入路(LA,40例)与开腹入路(OA,62例)。

主要发现

  • 两组人口学数据无显著差异;术前超声内镜活检45例(44%),两组间无差异。
  • LA组胰十二指肠切除术比例低于OA组(25% vs 53%,p=0.004),远端胰腺切除术比例高于OA组(40% vs 16%,p=0.003)。
  • LA-PD组发生1例死亡,中位失血量180 vs 200 ml(p=0.034),清扫淋巴结数11 vs 15枚(p=0.02)。
  • LA-DP组影像学中位肿瘤大小40 vs 80mm(p=0.048),中位手术时间135 vs 190分钟(p=0.028),中位综合并发症指数评分0 vs 8.7(p=0.048)。
  • LA-中央胰腺切除术组手术时间160 vs 240分钟(p=0.037),中位失血量60 vs 200 ml(p=0.043),清扫淋巴结数5 vs 2枚(p=0.025)。

关键数值与推荐

  • 中位随访60个月,观察到2例复发(2%),与手术入路无关。

临床怎么用

  • 作者认为LA治疗SPNP似乎是安全的,在大病灶行胰十二指肠切除术时应谨慎应用,且与复发无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Solid pseudopapillary neoplasms of the pancreas (SPNP) are rare tumors predominantly in young women. We report the largest single-center cohort study comparing resection of SPNP by laparoscopic approach (LA) and the open approach (OA). METHOD: Between 2001 and 2021, 102 patients (84% women, median age: 30) underwent pancreatectomy for SPNP and were retrospectively studied. Demographic, perioperative, pathological, early and the long-term results were evaluated between patients operated by LA and those by OA. RESULTS: Population included 40 LA and 62 OA. There were no significant differences in demographics data between the groups. A preoperative biopsy by endoscopic ultrasound was performed in 45 patients (44%) with no difference between the groups. Pancreatoduodenectomy (PD) was less frequently performed by LA (25 vs 53%, p = 0.004) and distal pancreatectomy (DP) was more frequently performed by LA (40 vs 16%, p = 0.003). In the subgroup analysis by surgical procedure, LA-PD was associated with one mortality, less median blood loss (180 vs 200 ml, p = 0.034) and fewer harvested lymph nodes (11 vs 15, p = 0.02). LA-DP was associated with smaller median tumor size on imaging (40 vs 80mm, p = 0.048), shorter surgery (135 vs 190 min, p = 0.028), and fewer complications according to the median comprehensive complication index score (0 vs 8.7, p = 0.048). LA-Central pancreatectomy was associated with shorter surgery (160 vs 240, p = 0.037), less median blood loss (60 vs 200, p = 0.043), and less harvested lymph nodes (5 vs 2, p = 0.025). After a median follow-up of 60 months, two recurrences (2%) were observed and were unrelated to the approach. CONCLUSIONS: The LA for SPNP appears to be safe, should be applied cautiously in case of PD for large lesion, and was not associated with recurrence.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Codjia T, Marique L, Aussilhou B, et al. Outcome and survival were similar with laparoscopic and open pancreatectomy in 102 solid pseudopapillary neoplasms. Surg Endosc. 2024. PMID: 38448620. doi:10.1007/s00464-024-10708-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。